Author of

• 25947

  +

  P2.10 - Prevention and Tobacco Control (Not CME Accredited Session) (ID 959)

  • Event: WCLC 2018
  • Type: Poster Viewing in the Exhibit Hall
  • Track:
  • Presentations: 1
  • Moderators:
  • Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall

  • 27091

    +

    P2.10-01 - Success of a Pharmacy-Driven Smoking Cessation Program (ID 11315)

    16:45 - 18:00  |  Author(s): Margaret Lang
    • Abstract
    • Slides

    Background
    

    While national oncology organizations advocate smoking cessation integrated into cancer management, only 30-40% of oncologists provide assistance with quitting. Barriers to providing this service are well documented. Pharmacy learners are poised to provide this intervention with the incorporation of smoking cessation therapies in accredited PharmD curricula. Previous pharmacist-driven programs reported 30-day quit rates of 23%. A pharmacy-driven pilot was initiated in April 2017 in a Thoracic Oncology Center of Excellence. The purpose of this study was to establish a new standardized infrastructure for a cessation program, determine its feasibility, and determine 30-day smoking cessation success rates for patients in a thoracic multidisciplinary clinic (MDC).

    a9ded1e5ce5d75814730bb4caaf49419 Method
    

    Patients seen in the thoracic MDC between April 2017 and March 2018 were included. Primary endpoints included patient capture rate in clinic, acceptance rate of tobacco assessment and smoking cessation counseling, and 30-day cessation rates. Tobacco use assessments and smoking cessation counseling were performed and documented by a pharmacy learner (pharmacy resident or student), under the supervision of a licensed pharmacist, prior to the history and physical by a health care provider. All patients who were active smokers or former smokers who quit within the last three months were offered cessation counseling and follow up. Nicotine replacement therapy was immediately available and provided to eligible patients based on tobacco use. Participants were followed up in clinic or by phone every two weeks for the first three months, at six months, nine months, and one year of program enrollment. At least two follow up phone call attempts were made until determined not successfully reached.

    4c3880bb027f159e801041b1021e88e8 Result
    

    One-hundred sixty-four of 189 patients seen in MDC were assessed by the pharmacy team. Forty-five (27%) of 164 assessed patients met eligibility criteria. Thirty-two (75%) of 45 eligible patients participated in same day counseling for smoking cessation and agreed to enroll in the follow up program. Quit rates at 30 days for enrolled patients were 44% (14/32). At one, three, and six months, 25%, 56%, and 81% of patients, respectively, were unavailable by phone.

    8eea62084ca7e541d918e823422bd82e Conclusion
    

    The majority of eligible patients enrolled in the smoking cessation program. More than 40% of enrolled patients were successful in smoking cessation at 30 days, which compares favorably to previous reports. Telephone follow up was challenging. Future efforts to expand smoking cessation in a comprehensive cancer center utilizing a pharmacy-driven intervention are warranted.

    6f8b794f3246b0c1e1780bb4d4d5dc53

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.